Abstract
US demand to grow 5.5% annually through 2012
Demand for pharmaceutical packaging products in the US is projected to grow
5.5 percent annually to $16 billion in 2012. The strongest influences on
growth will evolve from standards and regulations that address such issues as
patient drug compliance, drug dispensing errors, drug counterfeiting and drug
diversion. An increased focus on these issues will expand growth opportunities
for high value-added containers, closures and accessories, especially blister
packs, tamper-evident closures and RFID labels.
Plastic bottles to remain dominant primary container
Based on low cost and ease of processing advantages, plastic bottles will
remain the most widely used package for solid oral ethical drugs distributed
in large volume to retail and mail order pharmacies. The containers will also
continue to dominate applications involving OTC medicines, nutritional
preparations and herbal remedies sold in tablet and capsule quantities of 50
or more. Pharmaceutical blister packaging is well positioned for favorable
unit and revenue growth based on its adaptability to unit dose formats with
expanded label content and built-in track and trace features.
Parenteral containers will fare well in the US marketplace as advances in
biotechnology and related life science fields lead to the introduction of new
protein-based therapies that must be administered through injection or
infusion. Prefillable syringes will command the strongest growth opportunities
in this product group because of infection prevention and ease of use
advantages and the increasing availability of injectors for
self-administration. However, vials will continue to lead unit demand among
parenteral containers as a large percentage of existing and forthcoming
injectable drugs are produced in lyophilized or dry powder formulations not
easily adaptable to syringe packaging.
Study coverage
It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012
and 2017 by type and by market. The study also assesses market environment
factors and examines key trends in pharmaceutical packaging materials. In
addition, the study evaluates market share and profiles 30 producers and
contract providers in the US industry.
View Cart
